Boehringer Ingelheim
Type
investor
Founded
1885
Funding Rounds
4
Portfolio companies
4
About Boehringer Ingelheim
Boehringer Ingelheim is a leading research-driven, family-owned biopharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative medicines for humans and animals, operating in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing, with key areas including heart/metabolic, respiratory, oncology, and mental health, aiming to transform lives through long-term innovation.
Boehringer Ingelheim investments captured (4)
| Company Name | Stage | Total Deal Amount | Date |
|---|---|---|---|
| Unspecified | undisclosed | Dec 10, 2025 | |
| *********** | undisclosed | Dec 10, 2025 | |
| *********** | undisclosed | Jul 18, 2025 | |
| ************ | ***** | Feb 12, 2024 |